SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-18-028136
Filing Date
2018-04-30
Accepted
2018-04-30 09:03:15
Documents
3
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A a18-2974_3defa14a.htm DEFA14A 32432
2 GRAPHIC g29743bgi001.jpg GRAPHIC 177640
3 GRAPHIC g29743bgi002.jpg GRAPHIC 172320
  Complete submission text file 0001104659-18-028136.txt   515610
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35619 | Film No.: 18786930
SIC: 2834 Pharmaceutical Preparations